Financial results of Abbott Laboratories Limited for Quarter ended June 30, 2021

Karachi, Abbott Laboratories Limited informed Pakistan Stock Exchange about the recommendations made by the board of directors in the meeting held at Karachi on August 26, 2021.

The agenda of the meeting was discussion of profit and loss account for quarter ended June 30, 2021 which portrayed a profit of Rs. 1,839,497 with earnings per share 18.79 basic and diluted respectively.

Further, 200% payment of cash dividend, bonus shares and right shares was agreed.

Furthermore, the share transfer books of the company will remain closed from September 10, 2021 to September 17, 2021 (both days inclusive).

Abbott Laboratories Limited is a public limited company, incorporated in Pakistan on July 02, 1984, and principally engaged in the manufacturing, importing and marketing of research based pharmaceutical, nutritional, diagnostic, diabetic care, hospitals and consumer products.

The shares of the company are quoted on Pakistan Stock Exchange, and the symbol “ABOT” is being used for the shares.

Shares Company has issued are 97,900,302 where the Earnings per shares in 2020 is 46.33 which was 13.28 in 2019. The Profit after tax recorded in 2020 is 4,535,249,000 which was 1,299,885,000 in 2019.